Live

Synopsys, Inc. - Common Stock (SNPS) congressional disclosures

Sector not mapped · coverage May 15, 2024–Jul 21, 2026

Create a SNPS watch
Tracked disclosures
14
Lawmakers
8
Reported purchase / sale rows
7 / 7A disclosure count, not congressional market sentiment

Estimated market comparison · not an official filing fact

Available with Pro

Average post-trade price move across enriched rows. It is historical, sample-limited, does not account for exact execution prices or portfolio weights, and is not evidence that the filing activity caused a market move.

Disclosure alert preview

Based on a real public filing

Purchase

Alan Armstrong

SNPSSynopsys, Inc. - Common Stock

$1K - $15K

Traded
Mar 27, 2026
Filed
Jul 21, 2026
Disclosure delay
116 days
Reported owner
Not normalized

This watch matched after the disclosure became public. It is not a real-time trade signal. Source checked Aug 13, 2026.

Official filing

SNPS congressional trades snapshot

This page summarizes public STOCK Act disclosures involving SNPS. It is useful for seeing which lawmakers reported SNPS transactions, how many filings are visible, the buy/sell mix, and whether the newest public filing describes a recent or delayed trade.

Last updated

Jul 21, 2026

Data source

Public House and Senate STOCK Act disclosures normalized by Congressional Trader.

Key caveat

Filing date can trail transaction date. This page is for research and monitoring, not investment advice.

What the SNPS congressional trade page shows

Congressional Trader tracks 14 public STOCK Act disclosures for SNPSacross 8 lawmakers. This page separates purchases from sales, shows filing delays, and links each disclosure back to the individual politician profile when available.

The most recent SNPS filing shown here was filed on Jul 21, 2026 by Alan Armstrong as a purchase. Related lawmakers include Lisa C. McClain, Byron Donalds, Jefferson Shreve, Robert P. Bresnahan, Alan Armstrong.

FAQ

Which lawmakers traded SNPS?

Recent SNPS disclosures include Lisa C. McClain, Byron Donalds, Jefferson Shreve, Robert P. Bresnahan, Alan Armstrong.

What is the buy/sell mix for SNPS?

The visible sample currently shows 7 purchases and 7 sales or partial sales.

Should I trade based on SNPS disclosures?

No. This page summarizes public filings for research and monitoring. It is not investment advice.